Myriad Genetics Balance Sheet Health
Financial Health criteria checks 4/6
Myriad Genetics has a total shareholder equity of $783.2M and total debt of $38.5M, which brings its debt-to-equity ratio to 4.9%. Its total assets and total liabilities are $1.1B and $363.3M respectively.
Key information
4.9%
Debt to equity ratio
US$38.50m
Debt
Interest coverage ratio | n/a |
Cash | US$140.90m |
Equity | US$783.20m |
Total liabilities | US$363.30m |
Total assets | US$1.15b |
Recent financial health updates
Does Myriad Genetics (NASDAQ:MYGN) Have A Healthy Balance Sheet?
Mar 28Is Myriad Genetics (NASDAQ:MYGN) Using Debt Sensibly?
Aug 07Recent updates
Does Myriad Genetics (NASDAQ:MYGN) Have A Healthy Balance Sheet?
Mar 28An Intrinsic Calculation For Myriad Genetics, Inc. (NASDAQ:MYGN) Suggests It's 37% Undervalued
Feb 02Myriad Genetics' Strategic Growth Fuels Bullish Outlook
Jan 31Revenues Working Against Myriad Genetics, Inc.'s (NASDAQ:MYGN) Share Price
Dec 18Is Myriad Genetics (NASDAQ:MYGN) Using Debt Sensibly?
Aug 07Calculating The Intrinsic Value Of Myriad Genetics, Inc. (NASDAQ:MYGN)
Apr 13Myriad: Trying To Find Its Footing In An Evolving Industry
Sep 26Myriad Genetics receives expanded coverage in Japan for breast cancer diagnostic system
Aug 25Are Investors Undervaluing Myriad Genetics, Inc. (NASDAQ:MYGN) By 50%?
Aug 05Myriad Genetics Q2 2022 Earnings Preview
Aug 03Myriad Genetics touts study results of GeneSight test on depression remission rates
Jul 12Financial Position Analysis
Short Term Liabilities: MYGN's short term assets ($313.6M) exceed its short term liabilities ($155.9M).
Long Term Liabilities: MYGN's short term assets ($313.6M) exceed its long term liabilities ($207.4M).
Debt to Equity History and Analysis
Debt Level: MYGN has more cash than its total debt.
Reducing Debt: MYGN's debt to equity ratio has reduced from 25.7% to 4.9% over the past 5 years.
Debt Coverage: MYGN's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: Insufficient data to determine if MYGN's interest payments on its debt are well covered by EBIT.